Medical Device | July 19, 2023
Strand Life Sciences expands sequencing facility
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Cipla has a robust governance model focused on sustainability
PEEK brings a new quality to dental care for patients
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Subscribe To Our Newsletter & Stay Updated
